Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant
Shuhei Tsujino(Hokkaido University), Kei Sato(National Institute of Infectious Diseases)
Cited by 20
Related Papers
SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant
|Cell Reports|2020|438
An emerging SARS-CoV-2 mutant evading cellular immunity and increasing viral infectivity
|bioRxiv (Cold Spring Harbor Laboratory)|2021|74
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75
|bioRxiv (Cold Spring Harbor Laboratory)|2022|44
Virological characteristics of the SARS-CoV-2 BA.2.86 variant
|bioRxiv (Cold Spring Harbor Laboratory)|2023|24